NMC
XERS icon

NEA Management Company’s Xeris Biopharma Holdings XERS Stock Holding History

NEA Management Company’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-419,100
Closed -$926K – 44
2024
Q1 		$926K Buy
+419,100
New +$1.08M 0.06% 41
2023
Q1 		– Sell
-3,246,785
Closed -$4.32M – 56
2022
Q4 		$4.32M Hold
3,246,785
– – 0.24% 41
2022
Q3 		$5.07M Hold
3,246,785
– – 0.25% 42
2022
Q2 		$5M Hold
3,246,785
– – 0.26% 44
2022
Q1 		$8.31M Sell
3,246,785
-3,215
-0.1% -$7.85K 0.24% 45
2021
Q4 		$9.52M Buy
+3,250,000
New +$7.02M 0.19% 46

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

NEA Management Company's XERS Position: Q2 2024 in Review

NEA Management Company sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 419,100 shares — an estimated $926K sold.

NEA Management Company first reported a position in XERS in Q4 2021 and held it in 6 quarters. The position peaked at $9.52M in Q4 2021. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

  • NEA Management Company reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
  • NEA Management Company sold 419,100 Xeris Biopharma Holdings shares in Q2 2024, an estimated $926K.
  • NEA Management Company first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 6 quarters.
  • NEA Management Company's Xeris Biopharma Holdings position peaked at $9.52M in Q4 2021.
  • 134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on NEA Management Company's 13F filing for Q2 2024, filed 14 Aug 2024.